| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |